Article Information
History
- September 1, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jean-Louis Georges1,*,
- Floriane Gilles1,
- Hélène Cochet1,
- Alisson Bertrand1,
- Marie De Tournemire1,
- Victorien Monguillon1,
- Maeva Pasqualini1,
- Alix Prevot1,
- Guillaume Roger1,
- Joseph Saba1,
- Joséphine Soltani1,
- Mehrsa Koukabi-Fradelizi2,
- Jean-Paul Beressi3,
- Cécile Laureana4,
- Jean-François Prost1 and
- Bernard Livarek1
- 1Department of cardiology
- 2Emergency department
- 3Department of diabetology
- 4Department of medical information, Centre Hospitalier de Versailles, Le Chesnay, France
- ↵*Corresponding Author:
Jean-Louis Georges, MD, Hôpital André Mignot, 177 rue de Versailles, 78150 Le Chesnay, France (jgeorges{at}ch-versailles.fr) Tel: +33 1 39 63 88 67. Fax: +33 1 39 63 95 12
Posted September 01, 2020.
Positive association of Angiotensin II Receptor Blockers, not Angiotensin-Converting Enzyme Inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia
